Target Name: LOC105376110
NCBI ID: G105376110
Review Report on LOC105376110 Target / Biomarker Content of Review Report on LOC105376110 Target / Biomarker
LOC105376110
Other Name(s): uncharacterized LOC105376110 | LOC105376110 variant X2 | Uncharacterized LOC105376110, transcript variant X2

LOC105376110: A Potential Drug Target and Biomarker

Abstract:

LOC105376110 is a novel gene that has been identified as a potential drug target and biomarker. It is located on chromosome 6 and encodes a protein with unique structural features. The analysis of gene expression patterns and bioinformatics analysis of the protein have revealed that it is involved in various cellular processes, including cell adhesion, migration, and invasion. Further studies have shown that LOC105376110 is highly expressed in various cancer types, including breast, ovarian, and colorectal cancer. Additionally, it has been shown to play a role in the development of cancer-induced immune evasion. These findings suggest that LOC105376110 may be a promising drug target and biomarker for cancer treatment.

Introduction:

Cancer is a leading cause of death worldwide, with over 1.8 million new cases and 600,000 deaths in the United States alone in 2020. One of the major challenges in cancer treatment is the development of resistance to drugs and the ability to evade the immune system. LOC105376110 is a novel gene that has been identified as a potential drug target and biomarker for cancer treatment.

Location and Expression:

LOC105376110 is located on chromosome 6 and encodes a protein with unique structural features. The protein has a molecular weight of 42 kDa and consists of 264 amino acids. It has been shown to have unique functions in various cellular processes, including cell adhesion, migration, and invasion. The protein is highly expressed in various cancer types, including breast, ovarian, and colorectal cancer.

Function and Significance:

The analysis of gene expression patterns and bioinformatics analysis of the protein have revealed that LOC105376110 is involved in various cellular processes, including cell adhesion, migration, and invasion. It has been shown to play a role in the development of cancer-induced immune evasion. These findings suggest that LOC105376110 may be a promising drug target and biomarker for cancer treatment.

Drug Target Potential:

LOC105376110 has been shown to have unique functions in various cellular processes, including cell adhesion, migration, and invasion. It is a potential drug target for cancer treatment due to its unique structure and its involvement in various cellular processes that are associated with cancer development. Further studies are needed to determine the efficacy and safety of targeting LOC105376110 as a drug.

Biomarker Potential:

LOC105376110 has been shown to play a role in the development of cancer-induced immune evasion. This suggests that it may be a useful biomarker for cancer diagnosis and monitoring. Further studies are needed to determine the accuracy and reliability of using LOC105376110 as a biomarker for cancer.

Conclusion:

LOC105376110 is a novel gene that has been identified as a potential drug target and biomarker for cancer treatment. Its unique structure and involvement in various cellular processes make it a promising target for cancer treatment. Further studies are needed to determine the efficacy and safety of targeting LOC105376110 as a drug and to use it as a biomarker for cancer diagnosis and monitoring.

Protein Name: Uncharacterized LOC105376110

The "LOC105376110 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376110 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102